Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling

Immunology Letters

Volumn 147, Issue 1-2, 2012, Pages 47-54

  Mokarizadeh, Aram ^a   Delirezh, Nowruz ^a   Morshedi, Ahmad ^a   Mosayebi, Ghasem ^b   Farshid, Amir Abbas ^c   Mardani, Karim ^a  

^a URMIA UNIVERSITY   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c URMIA UNIVERSITY   (Iran)

Author keywords

Experimental autoimmune encephalomyelitis; Galectin 1; Mesenchymal stem cell; Microvesicle; PD L1; TGF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GALECTIN 1; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CYTOKINES; CYTOPLASMIC VESICLES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMAL CELLS; MICE; ORGANELLES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84865355844     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.06.001     Document Type: Article

References (46)

1. Keir M.E., Francisco L.M., Sharp A.H. PD-1 and its legends in T-cell immunity. Curr Opin Immunol 2007, 19:309-314.
2. Rabinovich G.A., Toscano M.A., Ilarregui J.M., Rubinstein N. Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. Glycoconjugate J 2004, 19:565-573.
3. Augello A., Tasso R., Negrini S., Amateis A., Indiveri F., Cancedda R., et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of Programmed Death 1 pathway. Eur J Immunol 2005, 35:1482-1490.
4. Di Ianni M., Del Papa B., De Loanni M., Moretti L., Bonifacio E., Cecchini D., et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 2008, 36:309-318.
5. Porada C.D., Almedia-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010, 62:1156-1166.
6. Prevosto C., Zancolli M., Canevali P., Raffaella Z.M., Poggi A. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007, 92:881-888.
7. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and diseases. J Nat Rev 2008, 8:726-736.
8. Thery C., Ostrowski M., Seyura E. Membrane vesicles as conveyors of immun responses. Nat Rev Immunol 2009, 9:581-593.
9. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosomes-mediated transfer of mRNA and micro-RNA is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
10. Camussi G., Deregibus M.C., Bruno S., Grang C., Fonsato V., Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011, 1(1):98-110.
11. Lai R.C., Arslan F., Lee M.M., Sze N.S.K., Choo A., Chen T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010, 4:214-222.
12. Farsad K. Exosomes novel organelles implicated in immunomodulation and apoptosis. Yale J Biol Med 2002, 75:95-101.
13. Buyanovskaya O.A., Kuleshov N.P., Nikitina V.A., Voronina E.S., Katosova L.D., Bochkov N.P. Spontaneous aneuploidy and clone formation in adipose tissue stem cells during different periods of culturing. Bull Exp Biol Med 2009, 148(1):109-112.
14. Zhou F.Y., Bosch-Marche M., Okuyama H., Krishnamachary B., Kimura H., Zhang L., et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 2006, 66:10849-10854.
15. Bruno S., Grange C., Deregibus M.C., Calogero R.A., Saviozzi S., Collino F., et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009, 20:1053-1067.
16. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005, 106(5):1755-1761.
17. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003, 422:688-694.
18. Théry C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of MVs from cell culture supernatants and biological fluids. Current Protocols in Cell Biology 2006, 1-29. John wiley & Sons, Inc., New York, Unit 3.22. J.S. Bonifacino, M. Dasso, J.B. Harford, J. Lippincott-Schwartz, K.M. Yamada (Eds.).
19. Bhatnagar S., Shinagawa K., Castellino F.J., Schorey J.S. MVs released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007, 110(9):3234-3244.
20. Gao K., Chen Y., Wei L., Li S., Jin X., Cong C., et al. Inhibitory effector of mesenchymal stem cell on Lymphocytes proliferation. Cell Biochem Func 2008, 26:900-907.
21. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H.G. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010, 162:1-11.
22. Wood K.J., Sakaguchi, Regulatory S. T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.
23. Stephens L.A., Gray D., Anderton S.M. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. PNAS 2005, 102(48):17418-17423.
24. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La-Rosa S., et al. Immuno-modulatory function of bone marrow-derived mesenchymal stem cell in experimental auto immune Type-1 diabetes. J Immunol 2009, 183:993-1004.
25. Pedemonte E., Benvenuto F., Casazza S., Mancardi G., Oksenberg J.R., Uccelli A., et al. The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. BMC Genomics 2007, 8:65.
26. Patel S.A., Meyer J.R., Greco S.J., Corcoran K.E., Bryan M., Rameshvar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 2010, 184:5885-5894.
27. Sharpe A.H., John Wherry E., Ahmed R., Freeman G.J. The function of programmed death-1 and its ligands in regulation of autoimmunity. Nat Immunol 2007, 8(3):239-245.
28. Volarevic V., Arsenijevic N., Lukic M.L., stojkovic M. Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 2011, 29:5-10.
29. Yamazaki T., Akibu H., Iwai H., Matsuda H., Aoki M., Tanno Y., et al. Expression of programmed death-1 ligand by murine T cell and APCs. J Immunol 2002, 169:5538-5542.
30. Sugita S., Usui Y., Horie S., Futagami Y., Aburatani H., Okazaki T., et al. T cell suppression by PD-L1 on retinal pigment epithelium during inflammatory conditions. IVOS 2009, 50(6):2862-2870.
31. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., et al. Engagement of the PD-1 immuno-inhibitory receptor by a novel B7 family member leads to negative regulation to lymphocyte activation. J Exp Med 2000, 192:1027-1034.
32. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development maintenance, and function of induced regulatory T cells. J Exp Med 2009, 206(13):3015-3029.
33. Guleria I., Khosroshahi A., Ansari M.J., Habicht A., Azuma M., Yagita H., et al. A critical role for the programmed death ligand-1 in fetomaternal tolerance. J Exp Med 2005, 202:231-237.
34. Keir M.E., Liang S.C., Guleria L., Latchman Y.E., Qipo A., Albacker L.A., et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. Exp Med 2006, 203(4):883-895.
35. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akibu H., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetic (NOD) mice. J Exp Med 2003, 196:63-69.
36. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., et al. PD-L1-deficient mice showed that PD-L1 on T cells: antigen presenting cells and host tissues negatively regulates T cells. PNAS 2004, 101(29):10691-10696.
37. Chen W., Jin W., Herdegen N., Lai K.J., Li L., Marinos N., et al. Convertion of peripheral CD4+CD25-naive T cell to CD4+CD25+ regulatory T cells by TGF-β. J Exp Med 2003, 198(12):1875-1886.
38. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., Neurath M.F. .Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad 7. J Immunol 2004, 172:5149-5153.
39. Kim M.J., Rasmussen J.P., Rudensky A.V. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, (8):191-197.
40. Zhang P., Su D.M., Liang M., Fu J. Chemopreventive agents induce programmed death-1 ligand (PD-L1). Surface expression in breast cancer cells and promote PD-L1 mediated T cell apoptosis. Mol Immunol 2007, 45:1740-1746.
41. Kadri T., Lataillade J.J., Doucet C., Marie A., Ernou I., Bourin P., et al. Proteomic study of galectin-1 expression in human mesenchymal stem cells. Stem Cells Dev 2005, 14(2):204-212.
42. Rabinovich G.A., Alonso C.R., Sotomayor C.E., Durand S., Bucco J.L., Riera C.M. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Differ 2000, 7(8):747-753.
43. Garín M.I., Chu C.C., Golshayan D., Cernuda-Morollón E., Wait R., Lechler R.I. Galectin-1: a key effector of regulation mediated by CD4 CD25T cells. Blood 2007, 109(5):2058-2065.
44. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007, 13(12):1450-1457.
45. Chen W., Frank M.E., Jin W., Wahl S.M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001, 14(6):715-725.
46. Pap E., Evaallinger E., Falus A. The role of membrane vesicles in tumorigenesis. Crit Rev Oncol/Hematol 2011, 79:213-223.